Fig. 6From: Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalitiesBaicalein inhibits abnormalities of B-cell distribution in a bleomycin-induced SSc model in mice. Mice were treated for 4 weeks. Spleen cells were collected to calculate the proportion of B cells (A) and CD27+ memory B cells (B). Quantitative data were the mean ± SEM from 9 mice in each group. #P < 0.05, ##P < 0.01 vs. NaCl-treated mice. * P < 0.05, ** P < 0.01 vs. bleomycin (BLM)-treated miceBack to article page